Jane Street’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-35,124
Closed -$443K 11743
2025
Q4
$480K Buy
35,124
+6,862
+24% +$127K ﹤0.01% 7777
2025
Q3
$616K Buy
+28,262
New +$333K ﹤0.01% 7403
2025
Q2
Sell
-156,814
Closed -$1.97M 9751
2025
Q1
$1.86M Sell
156,814
-65,493
-29% -$1.02M ﹤0.01% 4471
2024
Q4
$3.42M Buy
222,307
+121,083
+120% +$1.57M ﹤0.01% 3227
2024
Q3
$1.13M Sell
101,224
-42,851
-30% -$410K ﹤0.01% 5632
2024
Q2
$777K Buy
144,075
+126,169
+705% +$730K ﹤0.01% 6256
2024
Q1
$122K Sell
17,906
-11,413
-39% -$79.8K ﹤0.01% 8450
2023
Q4
$199K Buy
+29,319
New +$166K ﹤0.01% 8227
2023
Q2
Sell
-103,564
Closed -$874K 8760
2023
Q1
$874K Buy
103,564
+80,051
+340% +$701K ﹤0.01% 5265
2022
Q4
$199K Buy
23,513
+10,542
+81% +$99.9K ﹤0.01% 7671
2022
Q3
$134K Buy
+12,971
New +$171K ﹤0.01% 8471
2021
Q4
Sell
-16,887
Closed -$253K 10129
2021
Q3
$300K Buy
+16,887
New +$317K ﹤0.01% 8178

Other funds holding CLPT

Jane Street's CLPT Position: Q1 2026 in Review

Jane Street sold out of ClearPoint Neuro (CLPT) in Q1 2026, closing a stake of 35,124 shares — an estimated $443K sold.

Jane Street first reported a position in CLPT in Q3 2021 and held it in 12 quarters. The position peaked at $3.42M in Q4 2024. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Jane Street reported no remaining ClearPoint Neuro position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 35,124 ClearPoint Neuro shares in Q1 2026, an estimated $443K.
  • Jane Street first reported a position in ClearPoint Neuro in Q3 2021 and held it in 12 quarters.
  • Jane Street's ClearPoint Neuro position peaked at $3.42M in Q4 2024.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.